Publication | Open Access

Changes in serum interleukin-8 (IL-8) levels reflect and predict response to anti-PD-1 treatment in melanoma and non-small-cell lung cancer patients

Cancer ImmunosurveillanceAnti-pd-1 TreatmentMedicineMelanomaImmunologyImmune Checkpoint InhibitorImmunotherapyOncologyRadiation OncologyLung CancerImmunological Biomarkers